2025 Year-End Patient Centricity Review

Progress and Perspectives in Patient Centricity: 2025 Reflections

Patient centricity is a movement now. At Cactus Life Sciences, we don’t just follow the trend; we help set it. Here’s how your voices, our actions, and the industry’s bold steps made 2025 a landmark year...
Read More

Top Stories

Patient Centricity

The Evolution of Patient Centricity in Pharma

Patient centricity: A defining imperative in healthcare As...
AI in Scientific Publications

The Role of AI in Transforming Scientific

Scientific publishing is evolving rapidly with the advent of...
DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...
Rare diseases

Rare Diseases – An Evolving Medical Communications Landscape

A disease is considered rare when it affects fewer than 1 in 2,000 people. However...
AI in Medical Affairs & Medical Communications

Science, AI, and Human Ingenuity Converge to Transform Medical Affairs

Today, we're witnessing an unprecedented convergence of scientific advancement, artificial intelligence (AI) capabilities, and human...
Digital Strategies for Medical Affairs

CyberThink in Action: 3 Digital Strategies for Medical Affairs

Everyone is talking about how Medical Affairs needs to evolve and innovate by being open-minded...
Cactus Life Sciences Top 5 Trends of 2024

Cactus Life Sciences’ Top 5 Trends of 2024: Insights Driving Tomorrow’s MedComms

Here, we revisit our most thought-provoking articles and whitepapers, each addressing pivotal trends that influence...

The Paradigm Shift from Traditional Scientific Platforms to Integrated Communications Plans

In the rapidly evolving biopharma landscape, the approach to scientific communications is undergoing a significant...
Involve Medical Affairs in insight management, early phases of clinical trials, etc.

It’s Never Too Soon: How and When to Engage Medical Affairs

Engagement with Medical Affairs is critical at every juncture in the drug development process, with...

Learn more ABOUT our company.